» Articles » PMID: 32012389

GINS Complex Subunit 4, a Prognostic Biomarker and Reversely Mediated by Krüppel-like Factor 4, Promotes the Growth of Colorectal Cancer

Overview
Journal Cancer Sci
Specialty Oncology
Date 2020 Feb 4
PMID 32012389
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

GINS complex subunit 4 (GINS4) is essential for DNA replication initiation and elongation in the G /S phase cell cycle in eukaryotes, however, its functional roles and molecular mechanisms remain unclear in many aspects. Our study was designed to investigate the clinical significance, biological function, and molecular mechanism of GINS4 in colorectal cancer (CRC). First, we confirmed that GINS4 expression was significantly overexpressed in CRC cells and tissues. The immunohistochemical results in tissue microarray from 106 CRC patients showed that a high level of GINS4 expression was positively correlated with advanced T stage, higher tumor TNM stage, and poor differentiation. The results from univariate and multivariate survival analysis models based on 106 CRC patients revealed that GINS4 might serve as an independent prognostic indicator for overall survival and disease-free survival of CRC patients. Moreover, downregulated GINS4 can inhibit growth and the cell cycle and accelerate cell apoptosis progression in vitro as well as inhibit tumorigenesis in vivo. Besides, our results also indicated that Krüppel-like factor 4 (KLF4) can negatively regulate GINS4 expression at the transcriptional level and the KLF/GINS4 pathway might play a vital role in the growth and prognosis of CRC.

Citing Articles

PODXL promotes malignant progression of hepatocellular carcinoma by activating PI3K/AKT pathway.

Ding Y, Wang X, Shu F, Pan K, Chen X, Liu Q J Mol Histol. 2024; 55(6):1107-1120.

PMID: 39198365 DOI: 10.1007/s10735-024-10253-x.


Integrated whole transcriptome profiling revealed a convoluted circular RNA-based competing endogenous RNAs regulatory network in colorectal cancer.

Mollanoori H, Ghelmani Y, Hassani B, Dehghani M Sci Rep. 2024; 14(1):91.

PMID: 38167453 PMC: 10761719. DOI: 10.1038/s41598-023-50230-0.


A novel prognostic biomarker: is correlated with methylation and immune escape in liver hepatocellular carcinoma.

Lai T, Peng T, Li J, Jiang Y, Liu K, Yu W Transl Cancer Res. 2023; 12(5):1145-1164.

PMID: 37304536 PMC: 10248566. DOI: 10.21037/tcr-22-2565.


Krüppel-like Factors 4 and 5 in Colorectal Tumorigenesis.

Lee E, Cheung J, Bialkowska A Cancers (Basel). 2023; 15(9).

PMID: 37173904 PMC: 10177156. DOI: 10.3390/cancers15092430.


KLF4 transcription factor in tumorigenesis.

He Z, He J, Xie K Cell Death Discov. 2023; 9(1):118.

PMID: 37031197 PMC: 10082813. DOI: 10.1038/s41420-023-01416-y.


References
1.
Zhu Z, Yu Z, Rong Z, Luo Z, Zhang J, Qiu Z . The novel GINS4 axis promotes gastric cancer growth and progression by activating Rac1 and CDC42. Theranostics. 2019; 9(26):8294-8311. PMC: 6857050. DOI: 10.7150/thno.36256. View

2.
Feng J, Yang Y, Zhang P, Wang F, Ma Y, Qin H . miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb. J Cell Mol Med. 2014; 18(10):2125-34. PMC: 4244026. DOI: 10.1111/jcmm.12398. View

3.
Treinies I, PATERSON H, Hooper S, Wilson R, Marshall C . Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis. Mol Cell Biol. 1998; 19(1):321-9. PMC: 83890. DOI: 10.1128/MCB.19.1.321. View

4.
Lee J, Loh K, Yap Y . PI3K/Akt/mTOR inhibitors in breast cancer. Cancer Biol Med. 2016; 12(4):342-54. PMC: 4706528. DOI: 10.7497/j.issn.2095-3941.2015.0089. View

5.
MacNeill S . Structure and function of the GINS complex, a key component of the eukaryotic replisome. Biochem J. 2010; 425(3):489-500. DOI: 10.1042/BJ20091531. View